Document is current
Any future updates will be listed below
-
Authors
Sakai, Katsuya https://orcid.org/0000-0002-0443-1786
Sugano-Nakamura, Nozomi
Mihara, Emiko https://orcid.org/0000-0002-9127-8643
Rojas-Chaverra, Nichole Marcela https://orcid.org/0000-0003-1388-6384
Watanabe, Sayako
Sato, Hiroki
Imamura, Ryu
Voon, Dominic Chih-Cheng https://orcid.org/0000-0002-2963-9305
Sakai, Itsuki
Yamasaki, Chihiro
Tateno, Chise
Shibata, Mikihiro
Suga, Hiroaki https://orcid.org/0000-0002-5298-9186
Takagi, Junichi https://orcid.org/0000-0002-1219-475X
Matsumoto, Kunio https://orcid.org/0000-0002-6532-4482
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP21fk0210087)
Japan Agency for Medical Research and Development (JP19am0101090)
Japan Agency for Medical Research and Development (JP19am0101075)
MEXT | Japan Society for the Promotion of Science (20K06553)
MEXT | Japan Society for the Promotion of Science (21H01771)
MEXT | Japan Society for the Promotion of Science (19H03499)
MEXT | Japan Society for the Promotion of Science (21K18250)
- License Information
-
More Information
Article History
Received: 22 October 2021
Accepted: 26 September 2022
First Online: 7 November 2022
Competing interests
: H. Suga and J.T. are co-founders and shareholders of MiraBiologics Inc. E.M., K.S. and K.M. are also shareholders of the same company. The other authors declare no competing interests.
